Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
The process by which a female produces an offspring in their womb once the male and female zygotes have combined into a single embryo until birth.
The offspring in the womb, from the moment 2 zygotes co-exist up until the 11th week of pregnancy, is medically referred to as "Embryo"
The offspring in the womb, beginning on the 11th week of pregnancy, has graduated from "Embryo" to "Fetus"
The offspring, now emerged from the womb and ending the female's pregnancy.
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
An abnormality caused due to pathophysiological response to external or internal factors.
A disruption in normal functioning of mind or body due to a disease, genetic factor or trauma.
A set or collection of various identifying signs and symptoms that characterizes a certain disease or disorder.
An abnormal state of physical or mental health that interferes with usual activities or the feeling of well-being.
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]
Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]